Back to trial detailsIntake questionnaire
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Applying to Tidewater Kidney Specialists · Norfolk, Virginia
Answer a few short questions to share with the research team.
0 of 4 answered